Hosted on MSN21d
GLP-1 diabetes drugs not linked to heightened suicidality riskThe first two groups included 36,082 patients using GLP-1 receptor agonists and 234,028 patients using DPP-4 inhibitors between 2007 and 2020, while the other two groups included 32,336 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback